Rafael Amado - Aug 2, 2022 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
EVP of R&D and CMO
Signature
Veer Bhavnagri as attorney-in-fact for Rafael Amado
Stock symbol
ALLO
Transactions as of
Aug 2, 2022
Transactions value $
-$23,940
Form type
4
Date filed
8/2/2022, 05:40 PM
Previous filing
Jul 6, 2022
Next filing
Oct 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Sale -$23.9K -2K -0.37% $11.97 540K Aug 2, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in February 2022.